Characterizing and targeting class II/III BRAF alterations VJOncology 2:34 1 year ago 188 Далее Скачать
Rational for HER3-targeting in NRG1 fusion-positive NSCLC VJOncology 0:34 10 months ago 125 Далее Скачать
eNRGy: zenocutuzumab in NRG1 fusion-positive pancreatic ductal adenocarcinoma VJOncology 0:46 10 months ago 98 Далее Скачать
Optimizing and overcoming resistance to current KRAS inhibitors VJOncology 1:31 1 year ago 120 Далее Скачать
Avelumab and talazoparib in BRCA1/2- or ATM-mutant solid tumors VJOncology 1:59 1 year ago 75 Далее Скачать
Cancer Research Institute: Saving More Lives with Immunotherapy Cancer Research Institute 2:26 2 years ago 24 530 Далее Скачать
A Phase Ia/Ib trial of BGB-3245, a novel RAF dimer inhibitor, in solid tumors VJOncology 5:16 1 year ago 143 Далее Скачать
Phase I/II trial of zenocutuzumab for tumors with NRG1 fusions VJOncology 4:03 3 years ago 380 Далее Скачать
She's the Answer to Cancer...and So Are You Cancer Research Institute 2:10 8 years ago 9 057 Далее Скачать
Class II Speaker - James P. Allison American Academy of Arts & Sciences 11:45 6 years ago 1 942 Далее Скачать
Lecturer JD Schramm – Communicate with Mastery Stanford Graduate School of Business 57:38 4 years ago 21 986 Далее Скачать
Family First: Woman survives stroke thanks to being in the right place at right time News 8 WROC 3:02 3 years ago 92 Далее Скачать
Living Life to the Fullest Thanks to Research American Association for Cancer Research 5:13 6 years ago 13 794 Далее Скачать
